The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

Overview of attention for article published in Diabetologia, July 2009

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

blogs: 1 blog
policy: 3 policy sources
twitter: 8 X users

patent: 5 patents
facebook: 1 Facebook page
wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 975 Dimensions

Readers on

mendeley: 449 Mendeley
citeulike: 2 CiteULike

Summary Blogs Policy documents X Patents Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

PREDICTIVE BIOMARKERS FOR RISK OF BLADDER CANCER IN DIABETES PATIENTS

Application WO-2022128881-A1

World Intellectual Property Organisation (WIPO)

Biphasic single-chain insulin analogues

Grant US-11142560-B2

United States of America

Biphasic single-chain insulin analogues

Grant US-10392429-B2

United States of America

Photo-switchable sulfonylureas and their uses

Application EP-3009422-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 1 additional patents.